Suomi - suomi - Fimea (Suomen lääkevirasto)

dechra regulatory b.v. - amoxicillin trihydrate, potassium clavulanate - tabletti - 400 mg / 100 mg - amoksisilliini ja entsyymi-inhibiittori

Suomi - suomi - Fimea (Suomen lääkevirasto)

dechra regulatory b.v. - amoxicillin trihydrate, potassium clavulanate - tabletti - 40 mg / 10 mg - amoksisilliini ja entsyymi-inhibiittori

Suomi - suomi - Fimea (Suomen lääkevirasto)

dechra regulatory b.v. - amoxicillin trihydrate, potassium clavulanate - tabletti - 200 mg / 50 mg - amoksisilliini ja entsyymi-inhibiittori

Euroopan unioni - suomi - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfooma, mantle-cell - antineoplastiset aineet - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Suomi - suomi - Fimea (Suomen lääkevirasto)

macure pharma aps - amoxicillin sodium, potassium clavulanate - injektio-/infuusiokuiva-aine liuosta varten - 1000 mg / 200 mg - amoksisilliini ja beetalaktamaasin estäjä

Suomi - suomi - Fimea (Suomen lääkevirasto)

vetoquinol s.a. - potassium clavulanate, amoxicillin trihydrate - tabletti - 600 mg / 150 mg - amoksisilliini ja entsyymi-inhibiittori

Suomi - suomi - Adama

adama - tuohyönteisten torjunta

Euroopan unioni - suomi - EMA (European Medicines Agency)

virbac s.a. - halofuginonipitoisuudet - antiprototsooisia - vasikka, vastasyntynyt - in new born calves:- prevention of diarrhoea due to diagnosed cryptosporidium parvum, in farms with history of cryptosporidiosis,administration should start in the first 24 to 48 hours of age- reduction of diarrhoea due to diagnosed cryptosporidium parvum. antamisen tulisi alkaa 24 tunnin kuluessa ripulin alkamisesta. kummassakin tapauksessa ookystien erittymisen väheneminen on osoitettu.

Suomi - suomi - Fimea (Suomen lääkevirasto)

chemische fabrik kreussler & co gmbh - lauromacrogolum 400 - injektioneste, liuos - 10 mg/ml - polidokanoli

Euroopan unioni - suomi - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiset aineet - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.